文献速递细菌感染、耐药与抗菌药物医院感染防控

2021-22年全球抗菌药物耐药政策应对:161个国家的系统性治理分析

Global policy responses to antimicrobial resistance, 2021-22: a systematic governance analysis of 161 countries and territories.
PubMed 文献 · Lancet Infect Dis · 2025-09-03

结果显示治理评分与国家收入水平相关,高收入国家评分较高,且较高治理评分与较低的抗菌药物耐药相关伤残调整生命年和死亡负担显著相关。感染预防与控制、监测和抗菌药物管理是与较低耐药感染负担相关性最强的领域。

要点

  • 国家抗菌药物耐药治理评分与收入水平相关,高收入国家普遍较高。
  • 较高治理评分与较低的抗菌药物耐药相关伤残调整生命年和死亡负担显著相关。
  • 感染预防与控制、监测和抗菌药物管理是与较低耐药负担相关性最强的治理领域。

核心结论

  • 全球抗菌药物耐药应对受国家收入水平显著影响,治理能力存在全球差异。
  • 较高治理评分与较低的抗菌药物耐药相关伤残调整生命年和死亡负担显著相关。

研究设计与样本

  • 系统性治理分析,检索10个数据库至2023年4月1日,纳入161个国家和地区的国家抗菌药物耐药行动计划。
  • 使用机器学习和人工智能翻译非英语行动计划,3名研究者独立进行内容分析。
  • 采用主成分分析构建国家评分,通过Pearson相关系数评估评分与IHME GRAM项目耐药感染负担指标的相关性。

主要发现

  • 161个国家和地区纳入分析,较前次报告增加47个。
  • 挪威评分最高(100分),吉布提最低(0分)。
  • 高收入国家(如法国、美国、英国、瑞典、丹麦)评分较高,低收入国家评分较低。

临床怎么用

  • 国家抗菌药物耐药行动计划的设计和执行应优先纳入实施工具,尤其是改善感染预防与控制、抗菌药物使用监测系统和抗菌药物管理规划的措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most countries have endorsed a national action plan (NAP) on antimicrobial resistance. We previously used a governance framework to assess NAPs on antimicrobial resistance available for the period of 2020-21 from 114 countries, finding substantial variation worldwide in the commitment of resources to address an escalating global health challenge. We sought to expand and advance this analysis to include the NAPs of more low-income and middle-income countries, to cover the period of 2021-22, and to examine the strength of NAPs to address antimicrobial resistance. METHODS: In this systematic governance analysis, we searched ten repositories from their inception to April 1, 2023, to identify all publicly retrievable NAPs on antimicrobial resistance, with no language restrictions. Machine learning tools and artificial intelligence were used to translate all native-language NAPs into English. Three researchers independently conducted a detailed content analysis of new and updated NAPs on antimicrobial resistance. 22 057 datapoints were mapped against a governance framework and a numerical system was developed to quantify country scores for 54 indicators, 18 domains, and three governance areas. We applied principal component analysis to construct country scores between 0 and 100. Through Pearson's correlation coefficient, we evaluated the correlation between the country scores and various metrics pertaining to the burden of antibiotic-resistant infections from the IHME GRAM project. FINDINGS: 161 countries and territories were included in this analysis, 47 more than the previous report. Governance scores varied across countries, with Norway achieving the highest score (score of 100) and Djibouti the lowest (score of 0). Generally, higher scores were seen in high-income countries (eg, France, USA, UK, Sweden, and Denmark), whereas lower scores were more common in low-income countries. High-income regions performed well across governance domains, whereas lower scores were seen in other regions (eg, Libya, Central African Republic, South Sudan, and Seychelles). Higher governance scores were significantly associated with a lower burden of antimicrobial resistance-associated disability-adjusted life-years (r=-0·469, p<0·001) and death (r=-0·477, p<0·001). Infection prevention and control (r=-0·532, Bonferroni-adjusted p<0·001), surveillance (r=-0·482, Bonferroni-adjusted p<0·001), and stewardship (r=-0·459, Bonferroni-adjusted p<0·001) were the domains most strongly correlated with a lower burden of drug-resistant infections. INTERPRETATION: The global response to antimicrobial resistance was greatly affected by the income level of the nation, highlighting global disparities in antimicrobial resistance governance capacity. Lower scores in lower-income regions likely reflect systemic challenges, such as less public health spending and less access clean water and santiation. Implementation tools should be prioritised in the design and execution of NAPs, especially measures that improve infection prevention and control, surveillance systems for antimicrobial use, and stewardship programmes.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Patel J, Moghaddam SS, Ranganathan S, et al. Global policy responses to antimicrobial resistance, 2021-22: a systematic governance analysis of 161 countries and territories. Lancet Infect Dis. 2025. PMID: 40914183. doi:10.1016/S1473-3099(25)00406-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。